ASH Impact Series: David Steensma, MD - Examining Current Research Initiatives in MDS



David Steensma, MD, discusses current research initiatives in myelodysplastic syndromes, how clonal hematopoiesis of indeterminate potential connects with the development of myeloid neoplasms, and more. Dr. Steensma presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat Low Grade MDS." Visit for more on this topic and to watch other educational videos from ASH.


  • David Steensma, MD

back to top